Active pharmaceutical ingredient poly(ionic liquid)-based microneedles for the treatment of skin acne infection

Tikai Zhang1, Bin Sun2, Jiangna Guo1

  • 1Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, Department of Polymer Science and Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China.

Acta Biomaterialia
|August 28, 2020
PubMed

Insights

New microneedle (MN) patches loaded with salicylic acid (SA) offer a novel transdermal treatment for acne. These active pharmaceutical ingredient poly(ionic liquid) (API PIL)-based MNs effectively combat Propionibacterium acnes infection and inflammation.

Area of Science:

  • Materials Science
  • Dermatology
  • Nanotechnology

Background:

  • Acne vulgaris, driven by Propionibacterium acnes (P. acnes), involves inflammation and requires effective transdermal delivery methods beyond topical antibiotics.
  • The skin barrier poses a challenge for therapeutic penetration, necessitating advanced delivery systems.
  • Microneedle (MN) patches offer a promising platform for efficient transdermal drug delivery by creating micro-pathways through the epidermis.

Purpose of the Study:

  • To develop novel active pharmaceutical ingredient poly(ionic liquid) (API PIL)-based microneedle (MN) patches for enhanced transdermal delivery of salicylic acid (SA).
  • To evaluate the therapeutic efficacy of SA-loaded PIL-MNs against P. acnes infection and associated inflammation.
  • To explore the potential of these advanced MN patches for treating acne and other skin diseases.

Main Methods:

  • Fabrication of PIL-based MNs via photo-crosslinking of an ionic liquid monomer.
  • Anion exchange process to load salicylic acid anions (SA-) into the PIL-MNs.
  • In vitro and in vivo testing of SA-loaded PIL-MNs for anti-bacterial and anti-inflammatory effects on P. acnes-infected models.

Main Results:

  • Successfully synthesized SA-loaded PIL-MNs using a facile photo-crosslinking and anion exchange method.
  • Demonstrated significant therapeutic efficiency of the SA-loaded PIL-MNs in treating P. acnes infection both in vitro and in vivo.
  • Confirmed anti-bacterial and anti-inflammatory activities of the SA-loaded PIL-MNs in a P. acnes mouse model.

Conclusions:

  • The developed API PIL-based MN patches provide an effective strategy for transdermal delivery of salicylic acid for acne treatment.
  • These SA-loaded PIL-MNs show potential for improving topical treatment of bacterial skin infections like acne.
  • This approach highlights the versatility of PIL-based MNs for developing advanced therapeutic platforms for various skin diseases.